(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GULDEVRY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GULDEVRY

ST13

US500000088187138

Class

5

Filing

88187138

Registration

6932891

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

06/25/2026

Trademark type

Word

Nice classes

5

Filing date

11/08/2018

Registration date

12/27/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/27/2022

Last transaction

06/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

CARRIGTOHILL, CO. CORK, IE

Examiner

FATHY, DOMINIC

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

G. U. (pessoa física)

Representatives

Jack Wessel Gilead Sciences, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Publications

History of USPTO decisions and trademark events.

49 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/24/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/24/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/24/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/27/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/27/2022

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

11/21/2022

NREV

NOTICE OF REVIVAL - E-MAILED

11/17/2022

PG1B

PETITION GRANTED - REQUEST TO DELETE 1(B) FILED

11/17/2022

APET

ASSIGNED TO PETITION STAFF

11/14/2022

EPGS

TEAS PETITION TO REVIVE AND REQUEST TO DELETE 1B OR G/S

10/19/2022

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

10/17/2022

ABN6

ABANDONMENT - NO USE STATEMENT FILED

10/17/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

09/12/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/03/2022

EX5G

SOU EXTENSION 5 GRANTED

02/02/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/02/2022

EXT5

SOU EXTENSION 5 FILED

01/26/2022

EEXT

SOU TEAS EXTENSION RECEIVED

01/26/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/15/2021

EX4G

SOU EXTENSION 4 GRANTED

07/13/2021

EXT4

SOU EXTENSION 4 FILED

07/13/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/13/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/12/2021

EX3G

SOU EXTENSION 3 GRANTED

01/08/2021

EXT3

SOU EXTENSION 3 FILED

01/08/2021

EEXT

SOU TEAS EXTENSION RECEIVED

01/08/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/21/2020

EX2G

SOU EXTENSION 2 GRANTED

07/17/2020

EXT2

SOU EXTENSION 2 FILED

07/17/2020

EEXT

SOU TEAS EXTENSION RECEIVED

07/17/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/31/2020

EX1G

SOU EXTENSION 1 GRANTED

01/29/2020

EXT1

SOU EXTENSION 1 FILED

01/29/2020

EEXT

SOU TEAS EXTENSION RECEIVED

01/29/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/10/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/16/2019

PUBO

PUBLISHED FOR OPPOSITION

07/16/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/26/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/23/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/23/2019

ALIE

ASSIGNED TO LIE

05/23/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/17/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/13/2019

GNSL

LETTER OF SUSPENSION E-MAILED

02/13/2019

CNSL

SUSPENSION LETTER WRITTEN

02/13/2019

DOCK

ASSIGNED TO EXAMINER

02/13/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/27/2018

NWAP

NEW APPLICATION ENTERED

11/12/2018

Continuous trademark protection

Get notified about every new filing that threatens GULDEVRY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.